Consistent with previous studies, our functional validation results demonstrated that the knockdown of UBE2I significantly inhibited the growth, migration, and invasion abilities of HCC tumor cell lines, while simultaneously inducing apoptosis (Wang et al., 2020). Here, UBE2I is linked to hepatocellular carcinoma.